Related Experiment Video
Updated: Jun 29, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
The importance and evolution of bleeding disorder registries
Huyen Tran1,2, Renchi Yang3,4, Kathelijn Fischer5
1The Alfred Hospital, Melbourne, Victoria, Australia.
Bleeding disorder registries offer valuable data beyond clinical trials, aiding research and improving patient care globally. These registries track natural history, treatments, and outcomes, highlighting disparities and areas for focus in haemophilia management.
Area of Science:
- Hematology
- Public Health
- Clinical Research
Background:
- Randomized clinical trials (RCTs) have limitations in evaluating rare diseases.
- Registries provide real-world data on disease natural history, prevalence, and care models.
- Understanding variations in haemophilia care across different settings is crucial.
Purpose of the Study:
- To highlight the utility of bleeding disorder registries in advancing patient care.
- To showcase diverse registry data sources for haemophilia research.
- To identify differences in haemophilia care and outcomes globally.
Main Methods:
- Review of data from five key bleeding disorder registries.
- Inclusion of country-specific (Australia, China), pediatric (PedNet), surveillance (EUHASS), and demographic (WFH) registries.
- Analysis of data to understand treatment patterns, adverse events, and care models.
Main Results:
- Registries offer insights into natural history, prevalence, and treatment approaches.
- Global and regional registries reveal disparities in haemophilia care and outcomes.
- Data facilitates research, data sharing, and identification of unmet needs.
Conclusions:
- Bleeding disorder registries are essential for comprehensive research and patient care.
- Registry data supports evidence-based practice and policy development in haemophilia.
- Continued use of registry data will advance understanding and management of bleeding disorders.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Errors occurring during blood pressure monitoring
Several factors...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

